Smith, A. ., Pivavarchyk, M. ., Wooters, T. ., Zhang, Z. ., Zheng, G. ., McIntosh, J. ., … Dwoskin, L. . (2010). Repeated nicotine administration robustly increases bPiDDB inhibitory potency at alpha6beta2-containing nicotinic receptors mediating nicotine-evoked dopamine release. Biochemical Pharmacology, 80(3), 402-9. https://doi.org/10.1016/j.bcp.2010.03.018 (Original work published 2010)

Zhao, N. ., Zheng, G. ., Li, J. ., Zhao, H. ., Lu, C. ., Jiang, M. ., … Lu, A. . (2018). Text mining of rheumatoid arthritis and diabetes mellitus to understand the mechanisms of Chinese medicine in different diseases with same treatment. Chinese Journal of Integrative Medicine. https://doi.org/10.1007/s11655-018-2825-x (Original work published 2018)

Pan, Z. ., Chen, M. ., Zhang, Q. ., Wang, E. ., Yin, L. ., Xu, Y. ., … Yuan, J. . (2018). CD3-positive plasmablastic B-cell neoplasms: a diagnostic pitfall. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. https://doi.org/10.1038/modpathol.2017.177 (Original work published 2018)

Beckmann, J. ., Meyer, A. ., Pivavarchyk, M. ., Horton, D. ., Zheng, G. ., Smith, A. ., … Dwoskin, L. . (2015). r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement. Neurochemical Research, 40(10), 2121-30. https://doi.org/10.1007/s11064-015-1680-4

Wilmouth, C. ., Zheng, G. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2013). Oral administration of GZ-793A, a VMAT2 inhibitor, decreases methamphetamine self-administration in rats. Pharmacology, Biochemistry, and Behavior, 112, 29-33. https://doi.org/10.1016/j.pbb.2013.09.006

Meyer, A. ., Neugebauer, N. ., Zheng, G. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2013). Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo. Journal of Neurochemistry, 127(2), 187-98. https://doi.org/10.1111/jnc.12373

Dwoskin, L. ., Joyce, B. ., Zheng, G. ., Neugebauer, N. ., Manda, V. ., Lockman, P. ., … Crooks, P. . (2007). Discovery of a novel nicotinic receptor antagonist for the treatment of nicotine addiction: 1-(3-Picolinium)-12-triethylammonium-dodecane dibromide (TMPD). Biochemical Pharmacology, 74(8), 1271-82. https://doi.org/10.1016/j.bcp.2007.07.021 (Original work published 2007)

Dwoskin, L. ., Pivavarchyk, M. ., Joyce, B. ., Neugebauer, N. ., Zheng, G. ., Zhang, Z. ., … Crooks, P. . Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence. Nebraska Symposium on Motivation. Nebraska Symposium on Motivation, 55, 31-63. https://doi.org/10.1007/978-0-387-78748-0_4 (Original work published 2009)

Alvers, K. ., Beckmann, J. ., Zheng, G. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2012). The effect of VMAT2 inhibitor GZ-793A on the reinstatement of methamphetamine-seeking in rats. Psychopharmacology, 224(2), 255-62. https://doi.org/10.1007/s00213-012-2748-3

Beckmann, J. ., Denehy, E. ., Zheng, G. ., Crooks, P. ., Dwoskin, L. ., & Bardo, M. . (2012). The effect of a novel VMAT2 inhibitor, GZ-793A, on methamphetamine reward in rats. Psychopharmacology, 220(2), 395-403. https://doi.org/10.1007/s00213-011-2488-9